EDGAR Filing Documents for 0001600132-23-000039

Form 8-K - Current report:

SEC Accession No. 0001600132-23-000039

Filing Date

2023-05-05

Accepted

2023-05-05 16:59:35

Documents

Period of Report

2023-05-04

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	blph-20230504x8k.htm iXBRL	8-K	46620
2	EX-10.1	blph-20230504xex10d1.htm	EX-10.1	88765
	Complete submission text file	0001600132-23-000039.txt		270855

Data Files

Seq	Description	Document	Type	Size
3	EX-101.SCH	blph-20230504.xsd	EX-101.SCH	3139
4	EX-101.LAB	blph-20230504_lab.xml	EX-101.LAB	15264
5	EX-101.PRE	blph-20230504_pre.xml	EX-101.PRE	9666
7	EXTRACTED XBRL INSTANCE DOCUMENT	blph-20230504x8k_htm.xml	XML	4644

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)